建立并外部验证一个列线图模型,用于预测肿瘤大小对肝门部胆管癌患者生存的影响。

Development and external validation of a nomogram for predicting the effect of tumor size on survival of patients with perihilar cholangiocarcinoma.

机构信息

Key Laboratory on Living Donor Transplantation, Ministry of Health, Department of liver surgery, The First Affiliated Hospital of Nanjing Medical University, 300# Guangzhou Road, Nanjing, 210029, Jiangsu Province, China.

Department of Hepatobiliary and Laparoscopic Surgery, Yixing People's Hospital, Yixing, Jiangsu Province, China.

出版信息

BMC Cancer. 2020 Oct 30;20(1):1044. doi: 10.1186/s12885-020-07501-0.

Abstract

BACKGROUND

The effect of tumor size on account of long-term survival results in perihilar cholangiocarcinoma (PCCA) patients has remained a controversial debate. It is urgent necessary to identify the optimal cutoff value of tumor size in PCCA and integrate tumor size with other prognostic factors into a nomogram to improve the predictive accuracy of prognosis of patients with PCCA.

METHODS

Three hundred sixty-three PCCA patients underwent surgical resection were extracted from the Surveillance, Epidemiology and End Results (SEER) database. X-tile program was used to identify the optimal cutoff value of tumor size. A nomogram including tumor size was established to predict 1-, 3- and 5-year cancer-specific survival (CSS) based on the independent risk factors chosen by Kaplan-Meier methods and multivariable cox regression models. The precision of the nomogram for predicting survival was validated internally and externally.

RESULTS

PCCA patients underwent surgical resection were classified into 1-19 mm, 20-33 mm and ≥ 34 mm subgroups based on the optimal cutoff for tumor size in terms of CSS. And we noticed that more larger tumor size group had worse tumor grade, advanced T stage, more positive regional lymph nodes and more frequent vascular invasion. The nomogram according to the independent factors was well calibrated and displayed better discrimination power than 7th Tumor-Node-Metastasis (TNM) stage systems.

CONCLUSIONS

The results demonstrated that the larger tumor size of PCCA was, the worse survival would be. The proposed nomogram, which outperforms the conventional TNM staging system, showed relatively good performance and could be considered as convenient individualized predictive tool for prognosis of PCCA patients.

摘要

背景

肿瘤大小对长期生存结果的影响一直是肝门部胆管癌(PCCA)患者争论的焦点。迫切需要确定 PCCA 中肿瘤大小的最佳临界值,并将肿瘤大小与其他预后因素整合到列线图中,以提高 PCCA 患者预后预测的准确性。

方法

从监测、流行病学和最终结果(SEER)数据库中提取了 363 例接受手术切除的 PCCA 患者。X-tile 程序用于确定肿瘤大小的最佳临界值。基于 Kaplan-Meier 方法和多变量 cox 回归模型选择的独立风险因素,建立了一个包含肿瘤大小的列线图,以预测 1、3 和 5 年癌症特异性生存率(CSS)。内部和外部验证了列线图预测生存的准确性。

结果

根据 CSS 最佳肿瘤大小临界值,将接受手术切除的 PCCA 患者分为 1-19mm、20-33mm 和≥34mm 亚组。并且我们注意到,更大的肿瘤大小组具有更差的肿瘤分级、更晚期的 T 分期、更多的阳性区域淋巴结和更频繁的血管侵犯。根据独立因素的列线图具有良好的校准度,并显示出比第 7 版肿瘤-淋巴结-转移(TNM)分期系统更好的区分能力。

结论

结果表明,PCCA 的肿瘤越大,生存越差。所提出的列线图优于传统的 TNM 分期系统,表现出相对较好的性能,可作为 PCCA 患者预后的便捷个体化预测工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feed/7596930/71277b49e975/12885_2020_7501_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索